| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results|
Docs:
|
"Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023 SAN FRANCISCO, August 7, 2023 – Augmedix , a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and six months ended June 30, 2023. “This was another strong quarter for Augmedix, as we continue to solidify our position within the burgeoning ambient medical documentation market,” commented Manny Krakaris, Chief Executive Officer at Augmedix. “We set records for revenue, growing 47% year-over-year, and dollar-based net revenue retention at 148%, demonstrating that health systems and clinicians increasingly value ..." |
|
| 07/17/2023 |
4
| Faulkner Robert C. (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 shares
@ $0 |
|
| 07/17/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 shares
@ $0 |
|
| 07/17/2023 |
4
| FEBBO WILLIAM J (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| O'Reilly Roderick H. (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| Traylor Margie L. (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| MCGRAW LAURIE (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| Krikorian Jason (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 21,598 restricted stock units
@ $0 |
|
| 07/17/2023 |
8-K
| Resignation/termination of a director |
| 07/14/2023 |
8-K
| Quarterly results |
| 06/16/2023 |
4
| FEBBO WILLIAM J (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Exercised 52,632 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Traylor Margie L. (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Bought 26,530 shares
@ $4.51, valued at
$119.6k
Exercised 52,632 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| MCGRAW LAURIE (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Exercised 52,632 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Marks Joseph (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Exercised 52,632 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Krikorian Jason (10% Owner) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Exercised 52,632 restricted stock units
@ $0 |
|
| 06/15/2023 |
SC 13D/A
| Redmile Group, LLC reports a 44.7% stake in Augmedix, Inc. |
| 06/12/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/25/2023 |
4
| Shakil Ian (CHIEF STRATEGY OFFICER) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.84, valued at
$192k
Granted 150,000 options to buy
@ $3.84, valued at
$576k
|
|
| 05/19/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/18/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/17/2023 |
4
| Traylor Margie L. (Director) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Exercised 10,182 options to buy
@ $2.2, valued at
$22.4k
|
|
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/12/2023 |
8-K
| Investor presentation, Quarterly results |
| 05/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/04/2023 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Augmedix, Inc.|
Txns:
| Disposed of 5,000,000 shares
@ $3, valued at
$15M
Disposed of 7,446,146 shares
@ $3, valued at
$22.3M
Acquired 7,446,146 shares
@ $3, valued at
$22.3M
|
|
| 05/04/2023 |
3
| RedCo II Master Fund, L.P. (10% Owner) has filed a Form 3 on Augmedix, Inc. |
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/28/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/21/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/21/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/21/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|